MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Three distinct cases of methamphetamine induced movement disorders

    T.A. Clark, J. Kraakevik (Portland, OR, USA)

    Objective: To detail three cases of methamphetamine induced movement disorders with unique clinical phenotypes. Background: MA is an addictive psychostimulant that affects both the central…
  • 2016 International Congress

    Valproate-associated parkinsonism – A critical review of the literature

    F. Brugger, K.P. Bhatia, F.M.C. Besag (St. Gallen, Switzerland)

    Objective: To provide a critical review of the existing literature on valproate-associated parkinsonism and to discuss possible mechanisms. Background: Valproate was first approved as an…
  • 2016 International Congress

    MEK inhibitors have antidyskinetic effects in hemiParkinsonian rats that are associated with critical neurochemical alterations in the striatum

    G. Chen, S. Nie, K. Ma, C. Han, Y. Xu, Z. Zhang, S.M. Papa, X. Cao (Wuhan, People's Republic of China)

    Objective: To examine the effects of MEK inhibitors PD98059 and U0126 on L-DOPA-induced dyskinesia and the induced molecular changes. Background: L-DOPA-induced dyskinesia (LID) represents one…
  • 2016 International Congress

    Persistent drug-induced parkinsonism with normal dopamine transporter imaging

    J.W. Lee, J.Y. Hong, J.S. Oh, I. Lee, J.S. Kim, Y.H. Sohn, P.H. Lee (Wonju, Korea)

    Objective: We investigated whether patients with persistent drug-induced parkinsonism (DIP) showing visually normal dopamine transporter (DAT) imaging had minimal changes in striatal DAT activity using…
  • 2016 International Congress

    A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)

    H.H. Fernandez, S.A. Factor, R.A. Hauser, J. Jimenez-Shahed, W. Ondo, M.S. LeDoux, D. Shprecher, T. Simuni, D. Stamler, K.E. Anderson (Cleveland, OH, USA)

    Objective: To determine the efficacy and safety of deutetrabenazine (DTB) as a treatment for tardive dyskinesia (TD). Background: There is no approved treatment for TD,…
  • 2016 International Congress

    Ciprofloxacin as the cause of syndroma extrapiramidale

    D. Imamovic, N. Subasic, A. Nakicevic, E. Suljic (Sarajevo, Bosnia and Herzegowina)

    Objective: Ciprofloxacin in rare cases can cause paresthesia, dysesthesia, hypoesthesia, tremor, convulsions, dizziness . Background: The patient, 22 years old, comes in the emergency room,…
  • 2016 International Congress

    A survey of movement disorders in a large sample of patients treated with antipsychotic medication

    B. Balint, H. Killaspy, T.R.E. Barnes, N. Freemantle, E. Joyce, D. Martino, K.P. Bhatia (London, United Kingdom)

    Objective: To describe the prevalence and nature of movement disorders (MD) in a large sample of patients treated with antipsychotic medication. Background: Although there are…
  • 2016 International Congress

    Endoscopically-documented pharyngeal dystonia due to neuroleptic use without response to alcohol

    J.P. Squires, W.L. Severt, M.J. Pitman (New York, NY, USA)

    Objective: To review a case of endoscopically-documented pharyngeal dystonia and its response to alcohol. Background: Pharyngeal dystonia is a rare complication of neuroleptic use, resulting…
  • 2016 International Congress

    Lance-Adams syndrome with post-hypoxic myoclonus- physiotherapy intervention

    B. Cruz (Long Beach, CA, USA)

    Objective: To evaluate the benefit of physiotherapy (PT) interventions on functional limitations in a patient with Lance-Adams Syndrome (LAS) with post-hypoxic myoclonus using 10 meter…
  • 2016 International Congress

    The phenotypic and genetic features of myoclonus-dystonia in six Saudi Arabian kindreds

    S.A. Bohlega, A. Aldakheel, T. Alkhairallah, A. Alkhani, M. Almuhaizea, F. Alotaibi (Riyadh, Saudi Arabia)

    Objective: To study the motor symptoms, psychiatric and neuropsychological features and genetic findings of patients with familial dystonia with or without myoclonus in a movement…
  • « Previous Page
  • 1
  • …
  • 1613
  • 1614
  • 1615
  • 1616
  • 1617
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley